1. 31 Aug 2021  |  Global  |  Technology Research

    Research Efforts Fuel the Future of Global Obstructive Lung Disease Management

    Technology Developments Driving Transformational Growth in Treatment Modalities for Obstructive Lung Diseases

    Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

    $4,950.00

    Special Price $3,712.50 save 25 %

  2. 27 Aug 2021  |  North America  |  Market Research

    US and EU Upstream Bioprocessing Growth Opportunities

    Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing

    The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

    $4,950.00

    Special Price $3,712.50 save 25 %

  3. 24 Aug 2021  |  North America  |  Market Research

    US and EU Biotech Industry VC Investment Growth Opportunities

    Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

    With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

    $2,450.00

    Special Price $1,837.50 save 25 %

  4. 16 Aug 2021  |  North America  |  Market Research

    Global Drug Discovery and Early Development Outsourcing Growth Opportunities

    Growing Research and Development Pipelines of Emerging Biopharmaceutical and Niche Technology Providers Drive Competitive Intensity

    Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

    $4,950.00

    Special Price $3,712.50 save 25 %

  5. 12 Aug 2021  |  North America  |  Frost Radar

    Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

    A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

    Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

    $4,950.00

    Special Price $3,712.50 save 25 %

  6. 05 Aug 2021  |  Global  |  Market Research

    Global Wound Care Solutions and New-age Technology Growth Opportunities

    Growth Strategies Driven by Increasingly Advanced and Digital Solutions

    The entire healthcare industry is undergoing a transformation in the wake of the COVID-19 pandemic, and the global wound care industry is no exception. As concerns about aged patients contracting COVID-19 increased, care delivery began a gradual shift toward a home setting. As a result, participants in the wound care industry are investing heavily ...

    $4,950.00

    Special Price $3,712.50 save 25 %

  7. 04 Aug 2021  |  North America  |  Market Research

    Growth Opportunities Arising due to the Use of Commercial AI Models in Radiology

    The Intensely Competitive Landscape Necessitates the Repositioning of Value Through the Acceptance of New Business Models

    As artificial intelligence (AI) solutions gain acceptance in the imaging fraternity and among senior leaders in the health systems space, competition has intensified and necessitated the creation of differentiation strategies for companies that want to improve their revenue and sustain growth. The rapid proliferation of medical imaging AI companies...

    $2,450.00

    Special Price $1,837.50 save 25 %

  8. 03 Aug 2021  |  North America  |  Frost Radar

    Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021

    A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines

    During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes ...

    $4,950.00

    Special Price $3,712.50 save 25 %

  9. 27 Jul 2021  |  Global  |  Technology Research

    Wearable Artificial Organ Growth Opportunities

    Technological Innovations Enabling Remote Monitoring and Home Care for Organ Dysfunction

    Healthcare providers typically manage kidney failure, diabetes, and respiratory failure with large, bulky medical equipment in a hospital setting. Conventional interventions typically reduce patient mobility; the treatment burden, mental anxiety, potential for non-compliance, and other drawbacks for specific therapies can result in poor health outc...

    $4,950.00

    Special Price $3,712.50 save 25 %

  10. 23 Jul 2021  |  North America  |  Market Research

    US Digital Therapeutics Growth Opportunities

    Transformational Growth in New Business Models After COVID-19

    Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...

    $4,950.00

    Special Price $3,712.50 save 25 %